BMS-908662

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Colorectal CancerMelanoma

Phase 1

Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer

CompletedNCT01086267

Bristol-Myers SquibbColorectal Cancer

Start: 2010-07-31End: 2011-08-31Updated: 2016-06-27

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

CompletedNCT01245556

Bristol-Myers SquibbMelanoma

Start: 2011-01-31End: 2012-11-30Updated: 2013-06-12